Nutrien Ltd. (TSE:NTR - Free Report) - Stock analysts at Zacks Research cut their Q1 2025 earnings estimates for shares of Nutrien in a research note issued to investors on Tuesday, March 4th. Zacks Research analyst M. Agrawal now expects that the company will earn $0.36 per share for the quarter, down from their prior forecast of $0.49. The consensus estimate for Nutrien's current full-year earnings is $5.34 per share. Zacks Research also issued estimates for Nutrien's Q2 2025 earnings at $3.26 EPS, Q3 2025 earnings at $0.39 EPS, Q4 2025 earnings at $0.59 EPS, FY2025 earnings at $4.59 EPS, Q1 2026 earnings at $0.47 EPS, Q2 2026 earnings at $1.66 EPS, Q3 2026 earnings at $1.19 EPS, Q4 2026 earnings at $1.43 EPS and FY2026 earnings at $4.73 EPS.
Several other brokerages have also commented on NTR. Barclays lowered Nutrien from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, January 21st. Raymond James raised Nutrien from a "hold" rating to a "moderate buy" rating in a research note on Tuesday, December 3rd. Finally, Piper Sandler raised shares of Nutrien from a "strong sell" rating to a "strong-buy" rating in a research note on Monday, January 13th. Five research analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of C$59.00.
Read Our Latest Stock Report on NTR
Nutrien Price Performance
NTR traded up C$0.50 during trading on Friday, reaching C$73.90. The stock had a trading volume of 160,304 shares, compared to its average volume of 1,549,224. The business has a 50-day moving average of C$72.79 and a 200-day moving average of C$68.01. Nutrien has a one year low of C$60.74 and a one year high of C$83.14. The company has a debt-to-equity ratio of 59.10, a quick ratio of 0.65 and a current ratio of 1.27. The stock has a market cap of C$25.44 billion, a PE ratio of 34.79, a PEG ratio of 1.15 and a beta of 0.95.
Insider Buying and Selling
In other news, Director Michael Jeremiah Hennigan bought 5,000 shares of the firm's stock in a transaction dated Monday, February 24th. The stock was purchased at an average price of C$73.98 per share, with a total value of C$369,910.00. Also, Director Kenneth Alvin Seitz acquired 10,490 shares of the stock in a transaction on Tuesday, December 24th. The shares were purchased at an average cost of C$64.04 per share, with a total value of C$671,779.60. Insiders have bought a total of 16,840 shares of company stock valued at $1,138,741 over the last three months. 0.03% of the stock is owned by company insiders.
Nutrien Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, April 10th. Stockholders of record on Monday, March 31st will be issued a $0.545 dividend. This is a boost from Nutrien's previous quarterly dividend of $0.54. This represents a $2.18 annualized dividend and a dividend yield of 2.95%. Nutrien's dividend payout ratio (DPR) is currently 137.48%.
About Nutrien
(
Get Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Read More

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.